Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma.

Conclusion: CD133 is a good marker that can predict tumor recurrence and metastasis in gastric carcinoma. Even though, studies regarding CSCs are still in their initial stages especially those related to CD133 in gastric cancer. PMID: 31217618 [PubMed - in process]
Source: Pathologica - Category: Pathology Tags: Pathologica Source Type: research